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Abstract We previously mapped the sequences responsive to 
insulin/glucose stimulation and polyunsaturated fatty acid 
(PUFA) suppression in proximal promoter region from —57 to 
—35 of fatty acid synthase (FAS) gene of rat liver [Fukuda et al. 
(1996) Biochem. Mol. Biol. Int. 38, 987-996). When two copies 
of the sequences spanning —57 to —35 were linked to a reporter 
gene containing heterologous promoter and were used for 
transfection, the reporter activity significantly increased in 
response to insulin/glucose treatment in hepetocytes. This 
increase was inhibited by addition of PUFA. Gel mobility shift 
assays using the sequence from —57 to —35 as a probe revealed 
nuclear factor(s) from rat liver that specifically complexed with 
the sequences. In addition, by antibody supershift assays, we have 
detected the binding of the transcriptional factor Spl at the GC-
rich region located within —57 to —35 of the FAS promoter. 
Cotransfection studies in rat hepatocytes, with the Spl expres-
sion vector and FAScat constructs, showed the inactivation of the 
promoter. These results were similar to those for the region from 
—68 to —52 of FAS gene (an insulin response element). The 
region from —68 to —52 of FAS gene competed for the 
formation of DNA-protein complexes to the region from —57 to 
—35 in the gel shift assay. Mutational analysis showed that the 
overlapping region of these two sequences was essential for the 
binding of Spl. It has been demonstrated that both the regions 
from —57 to —35 and from —68 to —52 of the FAS gene are 
responsible for regulation due to insulin/glucose and PUFA, and 
Spl may be involved in the regulation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Fatty acid synthase (FAS) [EC 2.3.1.85], one of a set of 
lipogenic enzymes, catalyzes the synthesis of long-chain fatty 
acids. We previously reported that FAS gene expression is 
very low in fasted rat liver and greatly increased by refeeding 
a high carbohydrate diet, in a similar manner of other lipo-
genic enzymes [1,2]. Polyunsaturated fatty acid (PUFA) feed-
ing markedly decreased the gene expression. Moreover, the 
gene expression is very low in diabetic rat, and insulin treat-
ment causes a marked and rapid increase [1,2]. We previously 
mapped the responsive region to insulin/glucose stimulation 
and PUFA suppression in proximal promoter region from 
position —57 to position —35 of FAS by using the transfec-
tion system of cultured primary hepatocytes [3]. Nucleotides 
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—56 to —43 of the FAS gene have some sequence similarity to 
— 136 to —123 of the PUFA responsive region of L-type pyr-
uvate kinase (LPK) gene, and —60 to —49 of insulin/glucose 
and PUFA responsive region of ATP citrate-lyase (ACL) gene 
[3-5]. Moustaid et al. [6] found that insulin response sequen-
ces of FAS gene located in the region —68 to —52 in 3T3-L1 
adipocytes. In order to further investigate the transcriptional 
regulation of FAS gene, we have attempted to identify the ex-
acting DNA sequences responsible to glucose, insulin and 
polyunsaturated fatty acids by CAT assay, gel shift assay 
and antibody supershift assay. A synthetic nucleotide probe 
of —57 to —35 of FAS gene was used for transfection system 
in cultured hepatocytes of rat, comparing with a synthetic 
probe of —68 to —52 of FAS gene. 
2. Materials and methods 
2.1. Materials 
Restriction endonuclease and other enzymes were purchased from 
Takara Shuzo (Kyoto). The sequence kit, luciferase assay kit and 
acetyl-CoA were from Applied Biosystems, Toyo Ink (Tokyo) and 
Sigma, respectively. William's medium E was purchased from Flow 
Laboratories. Other culture media were obtained from Nissui Seiyaku 
(Tokyo). [14C]Chloramphenicol (2.22 GBq/mmol) and [y-32P]ATP 
(110 GBq/mmol) was from ICN. Antibody against Spl was from 
Santa Cruz Biotec. Lipofectin reagent was from Life Technologies. 
2.2. Plasmid constructs 
Plasmid pUCOcat, a promoter-less CAT vector, and pUC2cat, a 
CAT vector with simian virus 40 early enhancer and promoter were 
used as negative and positive controls, respectively [7]. Plasmid pactL, 
a luciferase vector containing p-actin enhancer and promoter, was 
used as an internal control to normalize for variations in transfection 
efficiency [8]. Plasmid FAScat57, which contains fragment of —57 to 
+79 of FAS gene, was produced from FAScatl604 (contain fragment 
— 1604 to +79) by 5'-deletion using exonuclease III [3]. Plasmid 
PLlcat, which contains fragment —94 to +37 of LPK gene, was pro-
duced from LPKcat [9]. Plasmid pRSV(Xho) and pRSVSpl [10] were 
generously gifted by Prof. Y. Fujii-Kuriyama (Touhoku University). 
The following single-stranded oligonucleotides were synthesized by 
GIBCO. 
FAS(-57/-35): 5'-GATCGTGGCCGCGCGGGGATGGCCGCG-3' 
3'-CACCGGCGCGCCCCTACCGGCGCCTAG-5' 
Mutant MSS(-57/-35) :5 '-GATCGTAATTACGCGGGGATGGCCGCG-3 ' 
3 ' -CATTAATGCGCCCCTACCGGCGCCTAG-5 ' 
FAS(-68/-52): 5'-GATCGCCCATGTGGCGTGGCC-3' 
3'-CGGGTACACCGCACCGGCTAG-5' 
ACL(-64/-41): 5'-GATCTGATGGGGGGCGGGGAGGAGCCCG-3' 
3'-ACTACCCCCCGCCCCTCCTCGGGCCCTAG-5' 
Spl: 5'-ATTCGATCGGGGCGGGGCGAGC-3' 
3'-TAAGCTAGCCCCGCCCCGCTCG-5' 
Double-stranded oligonucleotides of FAS(-57/-35) or FAS(-68/ 
—52) were inserted into the BamHI sites of PLlcat. The sequence of 
these inserts was verified by dideoxy sequencing, using a sequence kit 
[11]. Two copies of the sequences spanning —57 to —35 or —68 to 
—52 were linked to PLlcat. 
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2.3. Primary hepatocyte culture and transfection 
Male Wistar rats (200-250 g) maintained on a stock diet (Oriental 
Koubo, MF) were fasted for 16 h before experiments. The hepato-
cytes were isolated by the collagenase perfusion method [12] and 
plated at a density of 3X 106 cells/60 mm Primaria culture dish (Fal-
con). After a 6 h attachment period, medium was replaced with modi-
fied William's E media (lacking methyl linoleate) supplemented with 
5 mM glucose, 26 mM sodium bicarbonate, 2 mM glutamine and 
1 uM dexamethasone, and then mixtures of 2 ug of pactL and 18 ug 
each of CAT constructs were transfected into hepatocytes using lip-
ofectin for 16 h [13]. To explore the function of Spl, fixed amount 
(8 ug) of FAS(-57/-35) or FAS(-68/-52) linked to PLlcat and 2 ug 
of pactL were mixed with various amounts of pRSVSpl. Total 
amount of DNA was kept constant in a series of transfection experi-
ments by adding pRSV(Xho) as a carrier. Subsequently, cells were 
cultured for 48 h in experimental media (with 100 Ug/ml streptomycin 
and 100 U/ml penicillin) containing 20 mM glucose or 20 mM pyr-
uvate with or without 0.1 uM insulin. When included, 0.1 mM arach-
idonic acid was added. All transfections were performed at least 3 
times in duplicate. 
2.4. CAT and luciferase assay 
The cells were incubated for 48 h after transfection, harvested and 
lysed by sonication. Then 20 ul of the supernatant from each sample 
were assayed for luciferase using a kit [14]. Normalized amounts of 
the cell extracts by luciferase activity were used for CAT assays after 
heating at 60°C for 10 min [15,16]. Acetylated and nonacetylated 
forms of [14C]chloramphenicol were determined by scintillation coun-
ter and the percentages of the acetylated forms were calculated. 
2.5. Gel mobility shift assay 
Nuclear extracts were prepared as described by Gorski et al. [17]. 
End-labeled double-stranded oligonucleotide of FAS(—57/—35), FAS 
(—68/—52) or Spl was incubated with the indicated amount of nuclear 
proteins in 10 mM Hepes, pH 7.6, containing 75 mM KC1, 1 mM 
EDTA, 5 mM dithiothreitol, 5 mM MgCl2, 10% glycerol, 1 ug of 
poly(dl-dC), lXlO4 cpm 32P-labeled oligonucleotide probe (0.1 ng). 
The reaction mixture was incubated for 1 h at room temperature and 
then loaded onto an 8% non-denaturing polyacrylamide gel in 45 mM 
Tris, 45 mM borate, pH 8.3, and separated by electrophoresis at 100 
V for 4 h [9]. In competition studies, the indicated amounts of double-
stranded oligonucleotide were added to the reaction mixture. The 
nucleotide sequences of FAS(-57/-35), FAS(-68/-52), ACL [5] 
and Spl [18] are shown above. For antibody supershift assays, 2 ul 
of Spl antibody, was added to the binding reaction mixture and in-
cubated for 1 h at room temperature prior to adding the labeled 
probes. The gel was then fixed in 10% methanol, 10% acetic acid, 
dried, and autoradiographed. 
3. Results and discussion 
3.1. Identification of cis-active elements 
To explore possible regulatory elements in the 5'-flanking 
region of FAS gene, double-stranded oligonucleotides —57 to 
—35 of the FAS gene were synthesized and linked into 
PLlcat, which CAT activity was very low. The plasmid 
DNA was transfected to rat hepatocytes. The cells were cul-
tured in the presence of 20 mM glucose or 20 mM pyruvate 
with or without 0.1 uM insulin for 48 h, and the extracts were 
assayed for CAT activity. As shown in Table 1, the FAScat57 
(-S7/+79) and FAS(-57/-35) linked to PLlcat exhibited 
similar CAT activities in the presence of glucose and insulin. 
The result shows that the 23 bp sequence between —57 and 
—35 is sufficient to insulin/glucose responsive to the FAS gene. 
Moreover, pyruvate alone induced the CAT activity of 
FAS(—57/—35) linked to PL1 cat, in comparison with glucose 
alone. It is suggested that pyruvate stimulation did not neces-
sarily require insulin to confer the expression, whereas glucose 
stimulation required insulin. The insulin/glucose stimulation 
of the CAT activity of FAS(-57/-35) linked to PLlcat was 
reduced in arachidonic acid-treated cells, representing a 60% 
decline in the activity. PUFA appeared to suppress the insulin 
stimulation. This suggests the region between —57 and —35 of 
the FAS gene is responsive to PUFA suppression as well as 
insulin/glucose stimulation of this gene. 
Moustaid et al. [6] reported that insulin response sequences 
of the FAS gene may be located in the region from —68 to 
—52 in 3T3-L1 adipocytes, and sequences between —68 and 
—60 are essential for recognition and interaction with a trans-
acting factors. Therefore, FAS(—68/— 52) linked to PLlcat 
was transfected to rat hepatocytes and the extracts were as-
sayed for CAT activity. The insulin/glucose stimulation of the 
CAT activity of FAS(-68/-52) linked to PLlcat was similar 
to those of FAS(-57/-35) linked to PLlcat and FAScat57 
(—57/+79). However, pyruvate alone did not induce the CAT 
activity of FAS(-68/-52) linked to PLlcat, although pyru-
vate alone induced the activity of FAS(—57/—35) linked to 
PLlcat. The reason has not been elucidated. FAS(—57/—35) 
was at the region of GC-rich sequence in which Spl consensus 
sequence is found. This suggests the possible involvement of 
the Spl transcription factor in the insulin/glucose activation 
and/or the PUFA inactivation of promoter of FAS. 
3.2. Regulation of the FAS gene by Spl 
To determine directly the binding of Spl to these sequences, 
rat hepatocytes were cotransfected with FAS(—57/—35) or 
FAS(-68/-52) linked to PLlcat construct and the Spl ex-
pression vector (pRSVSpl). pRSV(Xho) was lack Spl sequen-
ces, and served as the negative control. The CAT activity of 
FAS(—57/—35) linked to PLlcat was reduced in the presence 
of the Spl expression vector (Fig. 1). It is suggested that the 
Spl consensus sequences located between —57 and —35 of the 
FAS gene can bind to Spl and that the bound Spl inactivated 
transcription. The CAT activity of FAS(—68/—52) linked to 
PLlcat was also reduced in the presence of the Spl expression 
vector. 
3.3. Gel mobility shift assays 
We examined DNA-protein binding activity of FAS(—57/ 
—35) or FAS(—68/—52) region by electrophoresis mobility 
shift assay. End-labeled oligonucleotide FAS(—57/—35) was 
incubated with nuclear extract of rat liver and subjected to 
Fig. 1. Effect of Spl on the expression of CAT activity driven by 
promoter. FAS(-57/-35) or FAS(-68/-52) linked to PLlcat (8 
ug) and pactL (2 ug) were cotransfected into rat hepatocytes with 
indicated amounts of pRSVSpl (the Spl expression vector) in a to-
tal amount of DNA (15 ug) adjusted with pRSV(Xho) (the empty 
vector). One of the typical results is shown. 
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Fig. 2. Gel mobility shift assays using liver nuclear extracts with end-labeled FAS(—57/—35). Increasing amounts of rat liver nuclear extracts 
were incubated in the presence of end-labeled oligonucleotide FAS(—57/—35). The species and molar ratios of competitor DNAs are indicated 
at the top. 
a non-denaturing polyacrylamide gel electrophoresis. Three 
bands of DNA-protein complexes were observed; the com-
plexes were competed away by increasing amount of unla-
beled oligonucleotide of FAS(-57/-35) (Fig. 2). Addition 
of the same amount of poly(dl-dC) or L-l oligonucleotide 
[9], which contains hepatocyte nuclear factor 1 binding site 
of the LPK gene, to gel mobility shift reactions had no com-
petition (data not shown). These results demonstrated specif-
icity of the DNA-protein complex formation. Excess unla-
beled FAS(—68/— 52) also could effectively compete for the 
formation of three bands to the labeled FAS(—57/—35). 
On the other hand, we showed previously that the ACL 
gene promoter segment —104 to —20 is the insulin/glucose 
stimulation and PUFA suppression response elements [5]. 
Since the similarity between nucleotides —54 to —43 of the 
FAS gene and —60 to —49 of the ACL gene was 9 out of 12, 
we tested whether this ACL sequence competes for the nuclear 
factors binding to FAS(—57/—35). As shown in Fig. 2, 
Table 1 
The CAT activities of the constructs of FAS gene 
Additions Relative CAT activity 
(%) 
FAScat57(-57/+79) 
FAS(-57/-35) linked to PLlcat 
FAS(-68/-52) linked to PLlcat 
PLlcat 
Glu 
Glu+Ins 
Glu+Ins+20:4 
Pyr 
Pyr+Ins 
Pyr+Ins+20:4 
Glu 
Glu+Ins 
Glu+20:4 
Glu+Ins+20:4 
Pyr 
Pyr+Ins 
Pyr+Ins+20:4 
Glu 
Glu+Ins 
Glu+20:4 
Glu+Ins+20:4 
Pyr 
Pyr+Ins 
Pyr+Ins+20:4 
Glu 
Glu+Ins 
42.7 
90.7 
37.1 
82.7 
106 
68.0 
60.2 
103 
64.1 
61.1 
87.3 
91.4 
64.2 
66.8 
117 
52.5 
56.2 
50.0 
113 
60.9 
1.2C 
1.31 
± 7.50 
±16.7 
± 7.42 
±15.5 
±21.2 
±12.6 
±10.0 
±14.8 
±15.2 
±18.1 
±12.5 
±25.6 
±20.0 
±14.3 
±14.8 
±19.4 
±19.3 
±10.2 
±20.7 
±21.0 
1+ 0.05 
± 0.07 
The constructs of the FAS gene (FAScat57(-57/+79), FAS(-57/-35) or FAS(-68/-52) linked to PLlcat, and PLlcat) were introduced into 
primary hepatocytes. The hepatocytes were incubated with or without 0.1 uM insulin (Ins) for 48 h in the presence of 20 mM glucose (Glu) or 20 
mM pyruvate (Pyr). When included, 0.1 mM arachidonic acid (20:4, n-6) was added. The percentage of acetylated forms of [14C]chloramphenicol 
were determined as the CAT activities for each sample. The relative CAT activities are expressed as percentage of that of pUC2cat. Mean ± SD of 
4 experiments are shown. 
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Fig. 3. Gel mobility shift assays using liver nuclear extracts with end-labeled FAS(—68/—52). Increasing amounts of rat liver nuclear extracts 
were incubated in the presence of end-labeled oligonucleotide FAS(—68/—52). The species and molar ratios of competitor DNAs are indicated 
at the top. 
ACL(-64/-41) oligonucleotide as well as FAS(-57/-35) it-
self, could effectively compete for the formation of the three 
bands of DNA-protein complexes at 5, 10 and 20 molar ex-
cess (in ratio) to labeled FAS(—57/—35) probe. Addition of 
the same amount of Spl probe to the gel mobility shift reac-
tions had effectively compete for the formation of band 2 and 
3 to the labeled FAS(-57/-35) probe. 
Moreover, end-labeled oligonucleotide FAS(—68/—52) was 
incubated with nuclear extracts of rat liver and subjected to a 
non-denaturing polyacrylamide gel electrophoresis. As shown 
in Fig. 3, two bands of DNA-protein were observed; the 
migration pattern of band 2 and band 3 due to end-labeled 
FAS (—68/—52) was very similar to band 2 and band 3 due to 
end-labeled FAS(-57/-35). Band 1 due to FAS(-57/-35) 
was missing in the migration pattern due to (FAS—68/—52). 
The two bands were competed away by increasing amounts of 
unlabeled oligonucleotide of FAS(-68/-52). FAS(-57/-35), 
ACL(-64/-41) and Spl oligonucleotide as well as FAS(-68/ 
—52) itself, could effectively compete for the formation of the 
two bands of DNA-protein complexes. Finally, end-labeled 
oligonucleotide Spl was incubated with nuclear extracts of rat 
liver and subjected to a non-denaturing polyacrylamide gel 
electrophoresis. The migration patterns of band 2 and band 
3 of the labeled FAS(-57/-35) and also the labeled 
FAS(—68/—52) were very similar to those formed by using 
end-labeled Spl (Fig. 4). FAS(-57/-35) and FAS (-68/ 
—52) as well as Spl itself, could effectively compete for the 
formation of bands to the labeled Spl probe. These results 
Fig. 4. Gel mobility shift assays using liver nuclear extracts with end-labeled Spl. The species and molar ratios of competitor DNAs are indi-
cated at the top. 
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Fig. 5. Gel mobility shift assays with mutant oligonucleotide of FAS(—57/—35) using liver nuclear extracts with end-labeled Spl or FAS(—57/ 
—35). The species and molar ratios of competitor DNAs are indicated at the top. 
suggested that Spl binds to FAS(—57/—35) as well as 
FAS(-68/-52). 
Spl was shown to bind to G / T
G / A G G C G
G / T
G / A
G / A
C / T 
decanucleotides, and multiple binding sites appear to be a 
common feature of promoters that are Spl responsive [20-
24]. FAS gene promoter region from —35 to —68 contains 
two potential overlapping binding sites for Spl family, which 
are nucleotides —57 to —48 and —62 to —53. The former 
region is included in FAS(—57/—35) oligonucleotides and 
the latter in FAS (-68/-52). 
We next tested this possibility using mutant oligonucleotide, 
mutated at the Spl site ( -55 to -51) of FAS(-57/-35), as 
competitor in DNA mobility shift assay. When oligonucleo-
tide of FAS (—57/—35) or Spl was end-labeled, it was not 
competed off with the excess unlabeled mutant of FAS gene 
(Fig. 5), suggesting the overlapping region in nucleotides of 
Fig. 6. DNA mobility supershift assay. Mobility shift assays were performed with or without Spl antibody. Labeled FAS(—57/—35), FAS(—68/ 
—52) and the consensus Spl were used as probes in the binding assay. 
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F A S ( - 5 7 / - 3 5 ) and ( - 6 8 / - 5 2 ) is essential for the binding of 
Sp l . 
To further demonstrate that Spl binding to the FAS gene, 
Spl-specific antibody was added to the gel mobility shift as-
say. After incubation of nuclear extract with FAS(—57/—35) 
or FAS(—68/—52) probe in the presence of Spl antibodies, 
band 3 resulted in supershift, as shown in Fig. 6. The super-
shift band above band 3 coincided with band 2. The result 
shows that band 3 represents an FAS(—57/—35) or F A S 
(—68/—52) specific p ro t e in -DNA complex, which contains 
Sp l . It was reported that the glucose activation of acetyl-
CoA carboxylase gene promoter II was mediated by a member 
of the Spl family of transcription factor [19], as members of a 
gene family, Sp l , Sp3 and Sp4 show similar structural char-
acteristics and identical D N A binding specificity [20,21]. It is 
possible that band 2 represent a complex due to other Spl 
family proteins, such as Sp3 and Sp4. 
Daniel and Kim [19] reported that the promoter II of ace-
tyl-CoA carboxylase gene (—340 to —249) was activated by 
high concentrations of glucose and the effect of glucose was 
mediated by Sp l . Moreover, they have shown that nuclear 
extracts from glucose-treated cells exhibit increased Spl bind-
ing activity [25]. This increase in the binding activity is not 
due to glucose-mediated changes in the amount of Spl in the 
nucleus but to an increase in the activity that modifies Spl so 
that it binds more effectively to the promoter sequence. On 
the other hand, Rolland et al. [26] reported that F A S pro-
moter activity mainly depended on a region from —200 to 
— 126 and this sequence exerted a strong negative effect on 
FAS promoter in adipocytes from lean rats but not in those 
from obese rats. They demonstrated that Spl or Spl-like pro-
teins were bound to this D N A subregion. 
The present studies demonstrated that the sequences located 
between —57 and —35 of the FAS gene can bind to Spl and 
that the bound Spl inactivated transcription. Similarly, the 
nucleotide —68 to —52 of FAS gene and the nucleotide —64 
to —41 of ACL gene [Fukuda et al., submitted] bound to Spl 
and the bound Spl inactivated its own transcription. On the 
other hand, these three nucleotides have been demonstrated to 
be the response elements of the insulin/glucose activation and 
the P U F A inactivation. Thus, we postulated that Spl is some-
how involved in the P U F A inactivation of the FAS genes and 
ACL gene. Further studies are required to address this ques-
tion. 
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